Evotec (EVO) News Today $2.97 -0.09 (-2.94%) Closing price 04:00 PM EasternExtended Trading$2.95 -0.02 (-0.67%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Evotec (NASDAQ:EVO) Shares Gap Down - Here's WhyEvotec (NASDAQ:EVO) Shares Gap Down - Should You Sell?April 4 at 10:29 AM | marketbeat.comRBC Capital Sticks to Its Buy Rating for Evotec (0IRF)March 29, 2025 | markets.businessinsider.comEvotec (NASDAQ:EVO) Sees Large Volume Increase - Should You Buy?Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Time to Buy?March 21, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Down - Here's What HappenedEvotec (NASDAQ:EVO) Shares Gap Down - What's Next?March 20, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Here's What HappenedEvotec (NASDAQ:EVO) Sees Large Volume Increase - Should You Buy?March 8, 2025 | marketbeat.comEvotec SE (EVO) Stock ForecastsMarch 7, 2025 | finance.yahoo.comEvotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Still a Buy?Evotec (NASDAQ:EVO) Sees Large Volume Increase - Here's What HappenedMarch 6, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Up - Here's What HappenedEvotec (NASDAQ:EVO) Shares Gap Up - Should You Buy?February 24, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Down - What's Next?Evotec (NASDAQ:EVO) Shares Gap Down - Here's What HappenedFebruary 20, 2025 | marketbeat.comAdvancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior PartnerFebruary 19, 2025 | businesswire.comEQS-DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan)February 7, 2025 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Gap Up - Time to Buy?Evotec (NASDAQ:EVO) Shares Gap Up - Still a Buy?February 5, 2025 | marketbeat.comWarburg Research Sticks to Its Buy Rating for Evotec (0IRF)February 3, 2025 | markets.businessinsider.comEvotec (NASDAQ:EVO) Sees Large Volume Increase - Still a Buy?Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Should You Buy?January 30, 2025 | marketbeat.comEvotec SE (NASDAQ:EVO) Short Interest Up 89.9% in JanuaryEvotec SE (NASDAQ:EVO - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 766,200 shares, an increase of 89.9% from the December 31st total of 403,500 shares. Based on an average trading volume of 232,100 shares, the short-interest ratio is presently 3.3 days. Approximately 0.3% of the company's shares are sold short.January 30, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Sees Large Volume Increase - Here's WhyEvotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - What's Next?January 22, 2025 | marketbeat.comEQS-News: Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseasesJanuary 22, 2025 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Down 3.6% - Here's WhyEvotec (NASDAQ:EVO) Stock Price Down 3.6% - Time to Sell?January 16, 2025 | marketbeat.comShort Interest in Evotec SE (NASDAQ:EVO) Rises By 89.9%Evotec SE (NASDAQ:EVO - Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 766,200 shares, a growth of 89.9% from the December 15th total of 403,500 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average daily trading volume, of 232,100 shares, the short-interest ratio is presently 3.3 days.January 14, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Down 3.6% - Here's What HappenedEvotec (NASDAQ:EVO) Shares Down 3.6% - Time to Sell?January 14, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Up - Here's WhyEvotec (NASDAQ:EVO) Shares Gap Up - Still a Buy?January 2, 2025 | marketbeat.comEvotec: Some Recovery Has Come, But Much More Is ExpectedDecember 29, 2024 | seekingalpha.comEvotec (NASDAQ:EVO) Trading Down 3% - Time to Sell?Evotec (NASDAQ:EVO) Trading Down 3% - What's Next?December 26, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Trading Up 9.4% - What's Next?Evotec (NASDAQ:EVO) Trading 9.4% Higher - Still a Buy?December 24, 2024 | marketbeat.comEvotec SE (NASDAQ:EVO) Short Interest Down 10.7% in NovemberEvotec SE (NASDAQ:EVO - Get Free Report) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 401,600 shares, a decline of 10.7% from the November 15th total of 449,700 shares. Based on an average trading volume of 197,200 shares, the short-interest ratio is presently 2.0 days. Approximately 0.1% of the shares of the stock are sold short.December 17, 2024 | marketbeat.comWellington Management Group LLP Buys 602,858 Shares of Evotec SE (NASDAQ:EVO)Wellington Management Group LLP lifted its position in Evotec SE (NASDAQ:EVO - Free Report) by 29.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,634,434 shares of the company's stock after purchasing an additional 602December 16, 2024 | marketbeat.comEQS-News: Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo NordiskDecember 11, 2024 | markets.businessinsider.comEvotec And Novo Nordisk Launch Projects For LAB EN² Drug Discovery AcceleratorDecember 11, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Gap Down - Should You Sell?Evotec (NASDAQ:EVO) Shares Gap Down - Here's WhyDecember 6, 2024 | marketbeat.comEvotec Chief Operating Officer to step down on December 31November 29, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Stock Price Down 2.7% - Here's WhyEvotec (NASDAQ:EVO) Shares Down 2.7% - Should You Sell?November 29, 2024 | marketbeat.comEvotec COO Craig Johnstone Steps DownNovember 29, 2024 | marketwatch.comHalozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cashNovember 24, 2024 | markets.businessinsider.comSan Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offerNovember 24, 2024 | msn.comHalozyme withdraws $2.1 bln buyout offer for EvotecNovember 22, 2024 | reuters.comHalozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in DiscussionsNovember 22, 2024 | prnewswire.comSan Diego biotech Halozyme makes $2.1B bid for German drugmakerNovember 21, 2024 | msn.comIs Evotec SE (EVO) the Best German Stock to Buy Now?November 19, 2024 | insidermonkey.comDeutsche Bank Remains a Sell on Evotec (0IRF)November 18, 2024 | markets.businessinsider.comHalozyme Provides Update on Non-Binding Proposal to Combine with EvotecNovember 18, 2024 | prnewswire.comEvotec SE (NASDAQ:EVO) Sees Significant Decrease in Short InterestEvotec SE (NASDAQ:EVO - Get Free Report) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 220,100 shares, a decline of 10.7% from the October 15th total of 246,500 shares. Based on an average daily volume of 138,900 shares, the short-interest ratio is presently 1.6 days. Currently, 0.1% of the shares of the stock are sold short.November 18, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Sees Large Volume Increase - Here's What HappenedEvotec (NASDAQ:EVO) Sees Strong Trading Volume - Still a Buy?November 15, 2024 | marketbeat.comEvotec jumps as Halozyme confirms takeover interest (updated)November 14, 2024 | seekingalpha.comHalozyme Therapeutics Bids to Acquire German Competitor EvotecNovember 14, 2024 | marketwatch.comHalozyme Therapeutics Proposes To Acquire Evotec For EUR 11.00/shr In CashNovember 14, 2024 | markets.businessinsider.comHalozyme interested in acquiring Evotec for $2.1B, Bloomberg saysNovember 14, 2024 | markets.businessinsider.comEvotec jumps on report Halozyme expressed takeover interestNovember 14, 2024 | msn.comGermany’s Evotec Gets Takeover Interest From HalozymeNovember 14, 2024 | bloomberg.comHalozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash TransactionNovember 14, 2024 | prnewswire.comHalozyme weighing buyout of drugmaker Evotec, Bloomberg News reportsNovember 14, 2024 | reuters.com Remove Ads Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address EVO Media Mentions By Week EVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVO News Sentiment▼1.110.64▲Average Medical News Sentiment EVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVO Articles This Week▼13▲EVO Articles Average Week Remove Ads Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA Biologics News PTC Therapeutics News Zai Lab News Organon & Co. News Arcellx News Avidity Biosciences News Ultragenyx Pharmaceutical News Rhythm Pharmaceuticals News SpringWorks Therapeutics News Akero Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVO) was last updated on 4/7/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
